GSK plc (GSK)

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging MarketBioMedWire Editorial Coverage: Oncology research is moving...

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Oncology research is moving...

Form SC TO-T - Tender offer statement by Third Party

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

First and only oral carbapenem antibiotic approved in the US Approval based on PIVOT-PO trial demonstrating non-inferiority compared to...

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating...

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]